Glyscend Therapeutics Employee Directory
Biotechnology ResearchMassachusetts, United States2-10 Employees
Glyscend Therapeutics is a biotechnology research company based in Lowell, Massachusetts. It develops oral, gut-targeted polymer therapeutics intended for metabolic conditions, including type 2 diabetes. Its lead drug candidate is designed to be taken orally, remain in the gastrointestinal tract, and be non-absorbed, with the aim of replicating the metabolic effects of bariatric surgery while avoiding invasive procedures. The approach focuses on delivering therapy within the gut to influence metabolic pathways with safety advantages over surgical options. As a small company within the biotechnology sector, Glyscend positions its work at the intersection of metabolic disease research and gut-targeted therapies. In September 2023, the company appointed Sapan A. Shah, Ph.D., as Chief Executive Officer.